CASE REPORT
Co-infection Paragonimiasis-pulmonary Tuberculosis Discovered from a Man in Abidjan, Côte d’Ivoire: Case Report
N’da Angbeletchi David AKA1, *, Fatoumata Coulibaly2, Mocket Adolphe Ehouman3, Ettawa Alphonse Dadie4
Article Information
Identifiers and Pagination:
Year: 2021Volume: 9
First Page: 5
Last Page: 8
Publisher Id: TOPARAJ-9-5
DOI: 10.2174/1874421402109010005
Article History:
Received Date: 4/12/2020Revision Received Date: 16/5/2021
Acceptance Date: 14/6/2021
Electronic publication date: 31/12/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction:
Paragonimiasis is a very uncommon zoonosis in sub-Saharan Africa. It is a trematodial disease contracted by eating fresh or undercooked crustaceans harboring a parasite of the genus Paragonimus. About fifteen species of Paragonimus are pathogenic to humans. In Africa, three species are frequently encountered: Paragonimus africanus, Paragonimus uterobilatéralis, and Paragonimus westermani. Clinically, it has similarities with pulmonary tuberculosis so that confusion is quickly made.
Case Report:
We report here a case of paragonimiasis discovered incidentally in a security guard man, 26 years old, originated from Côte d’Ivoire, who consulted in 2019 to the Medical Teaching Hospital of Cocody, for hemoptysis under a chronical mode.
Results:
After examination, the disease of paragonimiasis was diagnosed by positive direct smear. Otherwise, patient was positive to TB after a molecular test.
An anti-tuberculosis cure was proposed, and a treatment with praziquantel 600 mg (2 tabs x3 / d for 4 days) allowed us to obtain biological cure without major side effects for paragonimiasis.
Conclusion:
The diagnostic issues of paragonimiasis constitute a great challenge for health systems already weakened by the instability due to covid-19 pandemic. The insufficient resources allocated to the health sector showing the lack of integration of the diagnostics of paragonimiasis to pulmonary tuberculosis program are crucial.
The strengthening of human resources, as well as the improvement of the technical platform of reference laboratories in regions, are really needed.